Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Shortdax Daily Swap UCITS ETF 1c

LU0292106241 · LU0292106241 · EUR · domicile Luxembourg
Equity · EuropeinverseSFDR art. 6 (inferred)
Index tracked: SHORTDAX® DAILY INDEX (EUR)
TER
0.40%+ trans. 0.00%
Fund size
173 m EUR
Tracking difference
+0.18%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 5 Jun 2007 · costs from the KID as of 2 Sept 2026 · 37 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the ShortDAX® Index (index) which provides the opposite performance of the DAX® index (Underlying Index) plus a rate of interest. DESCRIPTION OF INDEX: This means the level of the index should rise when the Underlying index falls and fall when the Underlying Index rises on a daily basis. The interest rate added to the index level is based on double the rate at which banks in the Eurozone lend to each other on an overnight basis (as…

Performance since series start (in euro) — base 100

5 Jun 20078 Sept 2026 · dividends reinvested where declared by the issuer
20082011201420172020202320261991616
High 199 (9 Mar 2009) · low 16 (11 Aug 2026) · last 16. Past performance is not indicative of future results.

Returns in euro

1 year−7.3%
3 years−32.1%
5 years−34.6%
10 years−65.3%
Since series start−84.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.70%15.20%17.11%
Max drawdown−15.43%−38.55%−48.26%
Sharpe-0.48-0.96-0.57
Sortino-0.66-1.32-0.80
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0292106241 · LU02921062411
RebalixLU0292106241 · LU0292106241 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2024−10.36%−10.80%+0.44%
2023−12.88%−13.01%+0.13%
2021−16.46%−16.41%−0.04%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 37 securities · top-10 weight = 59.1%
Top holdingsWeight
TESLA INC8.9%
INTEL CORPORATION CORP8.5%
CME GROUP CLASS A7.2%
ALTRIA GROUP INC7.2%
BP PLC6.3%
CVS HEALTH4.5%
BRISTOL MYERS SQUIBB4.4%
NVIDIA4.2%
CATERPILLAR INC3.9%
CARDINAL HEALTH3.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
XSDX · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 27 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/01167ba6-568b-4079-849c-eb4d1bb384ae
Factsheet · etf.dws.com/download/asset/75cc7ff6-6d9a-46f9-aeb4-72b915b9266e
Prospectus · etf.dws.com/download/asset/97f28cea-2f24-445d-b135-f9c31a5f884d
The live sheet, always up to date
rebalix.com/en/etf/LU0292106241
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU0292106241 · LU02921062412